| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9871980 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusions: Patients with lower levels of plasma IL-8 before radiation therapy might be at increased risk for developing SRILI. Further studies are necessary to determine whether IL-8 levels are predictive of SRILI in a prospective trial and whether this marker might be used to determine patient eligibility for dose escalation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Justin P. Ph.D., Gloria M.S., Zahid M.D., Benjamin J. B.S., Robert B.A., Dale B.S., Gregory A. Ph.D., Mark D.V.M., Ph.D., Salvatore V. M.D., Ph.D., Zeljko M.D., Ph.D., Mitchell S. M.D.,